CXCL9 and lobular neoplasia: SLE‐LN patients showed significantly higher serum CXCL9 (p < .001, Figure 1A), CXCL10 (p < .001, Figure 1B), and CXCL11 (p < .001, Figure 1C) levels compared to SLE patients.